AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitalong M 100mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alteus Biogenics Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitalong M 100mg/500mg Tablet SR

Diabex Duo 100mg/500mg Extended-Release Tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Diabex Duo may be prescribed independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't universally suitable. Inform your doctor of any prior kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Interactions with other medications are possible; disclose all your medications for safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor your kidney function and blood sugar levels throughout treatment.

Uses of Sitalong M 100mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Sitalong M 100mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Sitalong M 100mg/500mg Sustained-Release tablets should be administered with a meal.

Common Side effects of Sitalong M 100mg/500mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalong M 100mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalong M 100mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Sitalong M 100mg/500mg Tablet SR works:

Sitalong M 100mg/500mg Extended-Release Tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Sitalong M 100mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Sitalong M 100mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Sitalong M 100mg/500mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalong M 100mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver disorders should likely refrain from using Sitalong M 100mg/500mg SR tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitalong M 100mg/500mg Tablet SR :

Should you forget a Sitalong M 100mg/500mg Tablet SR dose, take it immediately if possible. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Sitalong M 100mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Sitalong M 100mg/500mg Tablet SR

Sitalong M 100mg/500mg Extended-Release tablets contain sitagliptin and metformin. This medication treats type 2 diabetes, enhancing blood sugar control in adults when combined with a healthy diet and exercise regimen. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin blocks DPP-4 enzyme activity, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged use of Sitalong M 100mg/500mg sustained-release tablets can lead to vitamin B12 deficiency due to impaired intestinal absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures suggested by some researchers include annual supplemental vitamin B12 intake.
Sitalong M 100mg/500mg sustained-release tablets may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects such as lactic acidosis may also occur. Prolonged administration can result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M 100mg/500mg Tablet SR ingredient or additive should not take this medication. Its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M 100mg/500mg Tablet SR with alcohol is unsafe due to the heightened risk of lactic acidosis.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent accidental ingestion by children, pets, and others.
Sitalong M 100mg/500mg SR tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Patients with kidney impairment, the elderly, and heavy alcohol consumers should avoid this medication due to increased risk. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal pain, or bradycardia warrant immediate cessation of Sitagliptin + Metformin and urgent medical attention.
The extended-release tablet Sitalong M, containing 100mg of Sitagliptin and 500mg of Metformin, treats type 2 diabetes mellitus. This medication enhances glycemic control in adults when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin sensitivity, while Sitagliptin inhibits DPP-4, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalong M 100mg/500mg extended-release tablets may cause common adverse events including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M 100mg/500mg Tablet SR ingredient or inactive component should not take this medication. This medicine is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M 100mg/500mg Tablet SR and alcohol is unsafe due to a heightened risk of lactic acidosis.
Indeed, Sitagliptin/Metformin 100mg/500mg extended-release tablets may result in lactic acidosis. This serious medical condition, characterized by excessive blood lactic acid, is also termed Metformin-associated lactic acidosis (MALA). While uncommon with metformin, it necessitates caution in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow pulse. Should these symptoms arise, discontinue Sitagliptin/Metformin immediately and seek prompt medical attention.
Prolonged Sitalong M 100mg/500mg Tablet SR use can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency can manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Sitalong M 100mg/500mg Extended-Release tablets contain sitagliptin and metformin. This medication treats type 2 diabetes mellitus in adults, improving blood sugar control when combined with a healthy diet and exercise regimen. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin blocks DPP-4 enzyme activity, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18 years of age.
Sitalong M 100mg/500mg sustained-release tablets may cause common side effects including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M 100mg/500mg Tablet SR ingredient or inactive component should not use this medication. Its administration is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M 100mg/500mg Tablet SR with alcohol is unsafe due to a heightened risk of lactic acidosis.
Indeed, Sitagliptin/Metformin 100mg/500mg extended-release tablets can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin, prompting its avoidance in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sitagliptin/Metformin immediately and seek prompt medical attention.
Prolonged use of Sitalong M 100mg/500mg sustained-release tablets can lead to vitamin B12 deficiency due to impaired gastrointestinal absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some researchers include annual supplemental vitamin B12 intake.
Store this medication in its original, tightly sealed container or packaging, following the storage instructions provided on the label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitalong M 100mg/500mg Ta...
194
MRP 225
13% off